Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
IssueQ32020
Sort By
Newest First
1 / 3
1 / 3
Cover story
Restarting a Manufacturing Campus and Revitalizing a Community
Adam Covitt
Federal Equipment Company
PAP-Q3-20-CL-016
Sep 30, 2020
Nice Insight Overview
The Benefits of Expanding OSD Capacity
Nigel Walker
Nice Insight
PAP-Q3-20-NI-001
Sep 29, 2020
Equipment
Reshoring a Nation’s API and Pharmaceutical Production
Matt Hicks
Federal Equipment Company
PAP-Q3-20-CL-015
Sep 29, 2020
Microbiome CDMO
Extensive Experience Is Crucial to Speed to the Clinic and Market for Live Biotherapeutic Products
Aaron B. Cowley, Ph.D.
Arranta Bio
PAP-Q3-20-CL-004
Sep 29, 2020
Vaccine Distribution
Anticipating the Logistics of a COVID-19 Vaccination Effort
Andrew Boyle; Marc Boyle; Patrick Schafer
Boyle Transportation
PAP-Q3-20-CL-010
Sep 29, 2020
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
Nicholas Green
Avid Bioservices
PAP-Q3-20-CL-008
Sep 29, 2020
Parenterals
Trends Shaping the Dynamic Market for Parenterals
Marga Viñes
Grifols
PAP-Q3-20-CL-018
Sep 29, 2020
Integrated CDMO
Building an Integrated and Effective CDMO from the Ground Up
Tim Tyson
TriRx Pharmaceutical Services
PAP-Q3-20-CL-027
Sep 29, 2020
Recombinant Proteins
Innovation and Flexibility Drive Success During the COVID-19 Pandemic
Paul Magreta
Grifols Recombinant Protein CDMO
PAP-Q3-20-CL-019
Sep 29, 2020
Decentralized Trials
Facilitating the Full Spectrum of Decentralized Trials
Mamta Trivedi
Biorasi
PAP-Q3-20-CL-009
Sep 29, 2020
Northern Ireland
COVID-19 and the Growing Need for Dual-Source Supply Chains
Kevin Holland
PAP-Q3-20-CL-022
Sep 29, 2020
Decentralized Trials
Protecting Clinical Research and Patients Through Decentralized Trial Strategies
Brittany Erana; Alistair Davidson
PPD, part of Thermo Fisher Scientific
PAP-Q3-20-CL-025
Sep 29, 2020
Lipid Excipients
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies
Adela Kasselkus, Ph.D.; Shiksha Mantri, Ph.D.
MilliporeSigma
PAP-Q3-20-CL-024
Sep 29, 2020
Organ-on-a-Chip
Organ-on-a-Chip Technology Aims to Disrupt Traditional Drug Testing Models
Gustavo Mahler, Ph.D.; Jessica Davis
Dynamk Capital
PAP-Q3-20-CL-014
Sep 29, 2020
Bioanalysis
How Bioanalysis Supports the Development of New Cell and Gene Therapies
Timothy Sangster
Celerion
PAP-Q3-20-CL-012
Sep 29, 2020
Pharma/Biotech Advising
Data-Driven Decision-Making Throughout the Pharma Life Cycle
Stephan Kutzer, Ph.D.; Danielle A. Young
AKDYS
PAP-Q3-20-CL-001
Sep 29, 2020
Collaboration
Better Together: Collaborating to Simplify Complexities in Drug Development
Peter Soelkner; Frank Mathias, Ph.D.
Vetter Pharma International GmbH
PAP-Q3-20-CL-028
Sep 29, 2020
CRISPR RNPs
CRISPR RNPs and the Future of Cell and Gene Therapy
Thomas Lynch, Ph.D.
Aldevron
PAP-Q3-20-CL-002
Sep 29, 2020
Supply Chain
Introduction: The Evolving Pharmaceutical Supply
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-12
Sep 29, 2020
Feature Story
The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-002
Sep 29, 2020
